14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication

• Mercedes Bermejo,
• Juan Ambrosioni,
• Guiomar Bautista,
• Núria Climent,
• Elena Mateos,
• Cristina Rovira,
• Rafael Duarte,
• Francisco Cervantes,
• Montserrat Plana,
• José M. Miró,
• José Alcamí,
• Mayte Coiras

Affiliations

Mercedes Bermejo

Instituto de Salud Carlos III, Madrid, Spain

Juan Ambrosioni

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

Guiomar Bautista

Hospital Puerta de Hierro, Madrid, Spain

Núria Climent

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

Elena Mateos

Instituto de Salud Carlos III, Madrid, Spain

Cristina Rovira

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

Rafael Duarte

Hospital Puerta de Hierro, Madrid, Spain

Francisco Cervantes

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

Montserrat Plana

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

José M. Miró

Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

José Alcamí

Instituto de Salud Carlos III, Madrid, Spain

Mayte Coiras

Instituto de Salud Carlos III, Madrid, Spain